396 related articles for article (PubMed ID: 26350728)
1. Phelan McDermid Syndrome: From Genetic Discoveries to Animal Models and Treatment.
Harony-Nicolas H; De Rubeis S; Kolevzon A; Buxbaum JD
J Child Neurol; 2015 Dec; 30(14):1861-70. PubMed ID: 26350728
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genomic evaluation of a Chinese patient with a novel deletion associated with Phelan-McDermid syndrome.
Lei D; Li S; Banerjee S; Zhang H; Li C; Hou S; Chen D; Yan H; Li H; Peng HH; Liu S; Zhang X; Peng Z; Wang J; Yang H; Huang H; Wu J
Oncotarget; 2016 Dec; 7(49):80327-80335. PubMed ID: 27741506
[TBL] [Abstract][Full Text] [Related]
3. Interstitial 22q13 deletions not involving SHANK3 gene: a new contiguous gene syndrome.
Disciglio V; Lo Rizzo C; Mencarelli MA; Mucciolo M; Marozza A; Di Marco C; Massarelli A; Canocchi V; Baldassarri M; Ndoni E; Frullanti E; Amabile S; Anderlid BM; Metcalfe K; Le Caignec C; David A; Fryer A; Boute O; Joris A; Greco D; Pecile V; Battini R; Novelli A; Fichera M; Romano C; Mari F; Renieri A
Am J Med Genet A; 2014 Jul; 164A(7):1666-76. PubMed ID: 24700646
[TBL] [Abstract][Full Text] [Related]
4. Gait Abnormalities in Children with Phelan-McDermid Syndrome.
Frank Y; Levy T; Lozano R; Friedman K; Underwood S; Kostic A; Walker H; Kolevzon A
J Child Neurol; 2023 Dec; 38(13-14):665-671. PubMed ID: 37849292
[No Abstract] [Full Text] [Related]
5. A patient with the classic features of Phelan-McDermid syndrome and a high immunoglobulin E level caused by a cryptic interstitial 0.72-Mb deletion in the 22q13.2 region.
Simenson K; Õiglane-Shlik E; Teek R; Kuuse K; Õunap K
Am J Med Genet A; 2014 Mar; 164A(3):806-9. PubMed ID: 24375995
[TBL] [Abstract][Full Text] [Related]
6. Phelan-McDermid Syndrome and SHANK3: Implications for Treatment.
Costales JL; Kolevzon A
Neurotherapeutics; 2015 Jul; 12(3):620-30. PubMed ID: 25894671
[TBL] [Abstract][Full Text] [Related]
7. 22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan-McDermid syndrome.
Sarasua SM; Dwivedi A; Boccuto L; Chen CF; Sharp JL; Rollins JD; Collins JS; Rogers RC; Phelan K; DuPont BR
Genet Med; 2014 Apr; 16(4):318-28. PubMed ID: 24136618
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychological phenotype and psychopathology in seven adult patients with Phelan-McDermid syndrome: implications for treatment strategy.
Egger JI; Zwanenburg RJ; van Ravenswaaij-Arts CM; Kleefstra T; Verhoeven WM
Genes Brain Behav; 2016 Apr; 15(4):395-404. PubMed ID: 26824576
[TBL] [Abstract][Full Text] [Related]
9. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome).
Sarasua SM; Dwivedi A; Boccuto L; Rollins JD; Chen CF; Rogers RC; Phelan K; DuPont BR; Collins JS
J Med Genet; 2011 Nov; 48(11):761-6. PubMed ID: 21984749
[TBL] [Abstract][Full Text] [Related]
10. SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients.
Shcheglovitov A; Shcheglovitova O; Yazawa M; Portmann T; Shu R; Sebastiano V; Krawisz A; Froehlich W; Bernstein JA; Hallmayer JF; Dolmetsch RE
Nature; 2013 Nov; 503(7475):267-71. PubMed ID: 24132240
[TBL] [Abstract][Full Text] [Related]
11. Clinical, genetic, and cognitive correlates of seizure occurrences in Phelan-McDermid syndrome.
Levy T; Gluckman J; Siper PM; Halpern D; Zweifach J; Filip-Dhima R; Holder JL; Trelles MP; Johnson K; Bernstein JA; Berry-Kravis E; Powell CM; Soorya LV; Thurm A; Buxbaum JD; Sahin M; Kolevzon A; Srivastava S;
J Neurodev Disord; 2024 May; 16(1):25. PubMed ID: 38730350
[TBL] [Abstract][Full Text] [Related]
12. Deletion syndrome 22q13: what the dentist should know to manage children with Phelan-McDermid syndrome effectively.
Ivanoff C; Ivanoff AE
J Tenn Dent Assoc; 2014; 94(1):15-8; quiz 19-20. PubMed ID: 25241497
[TBL] [Abstract][Full Text] [Related]
13. Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder: case reports.
Serret S; Thümmler S; Dor E; Vesperini S; Santos A; Askenazy F
BMC Psychiatry; 2015 May; 15():107. PubMed ID: 25947967
[TBL] [Abstract][Full Text] [Related]
14. Autism spectrum disorder in Phelan-McDermid syndrome: initial characterization and genotype-phenotype correlations.
Oberman LM; Boccuto L; Cascio L; Sarasua S; Kaufmann WE
Orphanet J Rare Dis; 2015 Aug; 10():105. PubMed ID: 26306707
[TBL] [Abstract][Full Text] [Related]
15. Touchscreen learning deficits and normal social approach behavior in the Shank3B model of Phelan-McDermid Syndrome and autism.
Copping NA; Berg EL; Foley GM; Schaffler MD; Onaga BL; Buscher N; Silverman JL; Yang M
Neuroscience; 2017 Mar; 345():155-165. PubMed ID: 27189882
[TBL] [Abstract][Full Text] [Related]
16. [The Phelan-McDermid syndrome (22q13 microdeletion) - case report].
Slezak R; Laczmańska I
Med Wieku Rozwoj; 2011; 15(1):96-100. PubMed ID: 21786519
[TBL] [Abstract][Full Text] [Related]
17. The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome).
Phelan K; McDermid HE
Mol Syndromol; 2012 Apr; 2(3-5):186-201. PubMed ID: 22670140
[TBL] [Abstract][Full Text] [Related]
18. The deletion 22q13 syndrome: a new case.
Karaman A; Aydin H; Geçkinli B; Göksu K
Genet Couns; 2015; 26(1):53-60. PubMed ID: 26043508
[TBL] [Abstract][Full Text] [Related]
19. Phelan-McDermid syndrome: clinical report of a 70-year-old woman.
Verhoeven WM; Egger JI; Cohen-Snuijf R; Kant SG; de Leeuw N
Am J Med Genet A; 2013 Jan; 161A(1):158-61. PubMed ID: 23166010
[TBL] [Abstract][Full Text] [Related]
20. A translocation between Xq21.33 and 22q13.33 causes an intragenic SHANK3 deletion in a woman with Phelan-McDermid syndrome and hypergonadotropic hypogonadism.
Misceo D; Rødningen OK; Barøy T; Sorte H; Mellembakken JR; Strømme P; Fannemel M; Frengen E
Am J Med Genet A; 2011 Feb; 155A(2):403-8. PubMed ID: 21271662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
